Bausch Health Companies BHC
NYSE BHC
$6.82 -0.07 (-1.02%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)

Bausch Health Companies (BHC) posted Share-based Compensation of $54.0 million for Q2 2026, up 3.85% sequentially from $52.0 million in Q1 2026, and up 17.39% YoY from $46.0 million in Q2 2025.

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Share-based Compensation for 18 years, with the latest figure at $54.0 million in Q2 2026.

  • Quarterly Share-based Compensation rose 17.39% year-over-year to $54.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $233.0 million (up 37.06% YoY) and the FY2025 annual result came in at $216.0 million, up 44.0% from the prior year.
  • Share-based Compensation advanced to $54.0 million in Q2 2026 per BHC's latest filing, from $52.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $84.0 million in Q4 2025 and troughed at $26.0 million in Q2 2022.
  • A 5-year average of $40.6 million and a median of $37.0 million in 2024 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation slipped 21.95% in 2022, then jumped 95.35% in 2025.
  • Over 5 years, Share-based Compensation stood at $35.0 million in 2022, then dropped by 17.14% to $29.0 million in 2023, then jumped by 48.28% to $43.0 million in 2024, then soared by 95.35% to $84.0 million in 2025, then tumbled by 35.71% to $54.0 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $54.0 million, $52.0 million, and $84.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 40.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 26.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 114.12 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 19.00 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 30.40 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 65.00 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 7.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Bausch Health Companies 2.56 Bn 725.13 Mn 2.10 Bn 54.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 54.00 Mn
Jun 30, 2026 54.00 Mn
Mar 31, 2026 34.00 Mn
Mar 31, 2026 34.00 Mn
Dec 31, 2025 192.00 Mn
Dec 31, 2025 192.00 Mn
Sep 30, 2025 -65.00 Mn
Sep 30, 2025 -65.00 Mn
Jun 30, 2025 46.00 Mn
Jun 30, 2025 46.00 Mn
Mar 31, 2025 43.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 127.00 Mn
Dec 31, 2024 127.00 Mn
Sep 30, 2024 5.00 Mn
Sep 30, 2024 5.00 Mn
Jun 30, 2024 -15.00 Mn
Jun 30, 2024 -15.00 Mn
Mar 31, 2024 33.00 Mn
Mar 31, 2024 33.00 Mn